GlassScriptPhysician profile
Deborah V Suchman
NPI 1972055457
$850.52
in general payments reported to CMS, 2019-2025
9 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $137 · 2024: $225 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $220.85 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $133.62 | 2025 | Voquezna |
| Novo Nordisk INC | $122.17 | 2023-2025 | Wegovy, Saxenda, Rybelsus |
| Astellas Pharma US INC | $118.51 | 2024-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $97.30 | 2023-2024 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $66.31 | 2024-2025 | Inspire |
| Lilly USA, LLC | $40.28 | 2025 | Mounjaro, Zepbound |
| Seqirus USA INC | $32.68 | 2025 | Flucelvax, Fluad |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.80 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Suchman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.